Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcello Deraco

Showing results (161-170 of 178) with videos related to

Pageof 18
Sort By:
The Lancet. Oncology|April 2, 2026
Principles of cytoreductive surgery for primary and metastatic peritoneal malignancies-the PSOGI-ESGO-ISSPP Lyon consensusAditi Bhatt, Artem Stepanyan, Ahmed Al-Niaimi, et al.
British Journal of Cancer|June 5, 2020
Impact of hypoxia on chemoresistance of mesothelioma mediated by the proton-coupled folate transporter, and preclinical activity of new anti-LDH-A compoundsGiovanna Li Petri, Btissame El Hassouni, Rocco Sciarrillo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2024
Precision Oncology and Systemic Targeted Therapy in Pseudomyxoma PeritoneiJordi Martínez-Quintanilla, Débora Cabot, Doménico Sabia, et al.
Annals of Surgical Oncology|November 16, 2021
Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)Marco Tonello, Dario Baratti, Paolo Sammartino, et al.
Journal of Surgical Oncology|September 17, 2024
Review of 2022 PSOGI/RENAPE Consensus on HIPECShigeki Kusamura, Aditi Bhatt, Kurt van Der Speeten, et al.
Annals of Surgical Oncology|May 24, 2014
The American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 Patients with Colorectal Cancer with Peritoneal CarcinomatosisJesus Esquivel, Andrew M Lowy, Maurie Markman, et al.
Journal of Surgical Oncology|December 17, 2018
Iterative cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A multi-institutional experienceNayef A Alzahrani, Sarah J Valle, Oliver M Fisher, et al.
Annals of Surgical Oncology|April 6, 2022
Correction: Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)Marco Tonello, Dario Baratti, Paolo Sammartino, et al.
Annals of Surgical Oncology|October 13, 2023
Is Systemic Chemotherapy Useful in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Metastases? A Propensity-Score AnalysisMarco Tonello, Dario Baratti, Paolo Sammartino, et al.
Journal of Surgical Oncology|August 5, 2014
The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgeryArancha Prada-Villaverde, Jesus Esquivel, Andrew M Lowy, et al.
Pageof 18

Showing results (161-170 of 178) with videos related to

Sort By:
Pageof 18
The Lancet. Oncology|April 2, 2026
Principles of cytoreductive surgery for primary and metastatic peritoneal malignancies-the PSOGI-ESGO-ISSPP Lyon consensusAditi Bhatt, Artem Stepanyan, Ahmed Al-Niaimi, et al.
British Journal of Cancer|June 5, 2020
Impact of hypoxia on chemoresistance of mesothelioma mediated by the proton-coupled folate transporter, and preclinical activity of new anti-LDH-A compoundsGiovanna Li Petri, Btissame El Hassouni, Rocco Sciarrillo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2024
Precision Oncology and Systemic Targeted Therapy in Pseudomyxoma PeritoneiJordi Martínez-Quintanilla, Débora Cabot, Doménico Sabia, et al.
Annals of Surgical Oncology|November 16, 2021
Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)Marco Tonello, Dario Baratti, Paolo Sammartino, et al.
Journal of Surgical Oncology|September 17, 2024
Review of 2022 PSOGI/RENAPE Consensus on HIPECShigeki Kusamura, Aditi Bhatt, Kurt van Der Speeten, et al.
Annals of Surgical Oncology|May 24, 2014
The American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 Patients with Colorectal Cancer with Peritoneal CarcinomatosisJesus Esquivel, Andrew M Lowy, Maurie Markman, et al.
Journal of Surgical Oncology|December 17, 2018
Iterative cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A multi-institutional experienceNayef A Alzahrani, Sarah J Valle, Oliver M Fisher, et al.
Annals of Surgical Oncology|April 6, 2022
Correction: Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)Marco Tonello, Dario Baratti, Paolo Sammartino, et al.
Annals of Surgical Oncology|October 13, 2023
Is Systemic Chemotherapy Useful in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Metastases? A Propensity-Score AnalysisMarco Tonello, Dario Baratti, Paolo Sammartino, et al.
Journal of Surgical Oncology|August 5, 2014
The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgeryArancha Prada-Villaverde, Jesus Esquivel, Andrew M Lowy, et al.
Pageof 18